A Single Centre, Single Dose, Open-label, Randomised, 2-way Crossover Study in Healthy Japanese Male Subjects to Evaluate the Bioequivalence of Daprodustat Tablets (2 mg Tablet vs. 4 mg Tablet) (Part 1) and the Food Effect on the Pharmacokinetics of Daprodustat (Part 2)
Phase of Trial: Phase I
Latest Information Update: 13 Jul 2018
At a glance
- Drugs Daprodustat (Primary)
- Indications Anaemia
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 05 Jul 2018 Status changed from active, no longer recruiting to completed.
- 29 May 2018 Status changed from recruiting to active, no longer recruiting.
- 22 May 2018 Planned primary completion date changed from 1 Jun 2018 to 10 Jun 2018.